![](https://www.buystockseasy.com/wp-content/themes/bse/images/no-logo.png?x23555)
Flora Growth Corp
Prices are adjusted according to historical splits.
![Flora Growth Corp Stock Price](https://www.buystockseasy.com/wp-content/transient/charts/flgc.png?x23555)
Vitals
- Today's Low:
- $3.4
- Today's High:
- $3.74
- Open Price:
- $3.54
- 52W Low:
- $0.172
- 52W High:
- $1.27
- Prev. Close:
- $3.66
- Volume:
- 124694
Company Statistics
- Market Cap.:
- $31.93 million
- Book Value:
- 0.395
- Revenue TTM:
- $52.33 million
- Operating Margin TTM:
- -42.97%
- Gross Profit TTM:
- $2.43 million
- Profit Margin:
- -93.11%
- Return on Assets TTM:
- -20.33%
- Return on Equity TTM:
- -74.92%
Company Profile
Flora Growth Corp had its IPO on 2021-05-11 under the ticker symbol FLGC.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Flora Growth Corp has a staff strength of 337 employees.
Stock update
Shares of Flora Growth Corp opened at $3.54 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $3.4 - $3.74, and closed at $3.4.
This is a -7.1% slip from the previous day's closing price.
A total volume of 124,694 shares were traded at the close of the day’s session.
In the last one week, shares of Flora Growth Corp have slipped by -6.34%.
Flora Growth Corp's Key Ratios
Flora Growth Corp has a market cap of $31.93 million, indicating a price to book ratio of 0.3905 and a price to sales ratio of 0.7052.
In the last 12-months Flora Growth Corp’s revenue was $52.33 million with a gross profit of $2.43 million and an EBITDA of $-19370000. The EBITDA ratio measures Flora Growth Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Flora Growth Corp’s operating margin was -42.97% while its return on assets stood at -20.33% with a return of equity of -74.92%.
In Q1, Flora Growth Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 306.5%.
Flora Growth Corp’s PE and PEG Ratio
- Forward PE
- 72.4638
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.59 per share while it has a forward price to earnings multiple of 72.4638 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Flora Growth Corp’s profitability.
Flora Growth Corp stock is trading at a EV to sales ratio of 0.6142 and a EV to EBITDA ratio of -0.3785. Its price to sales ratio in the trailing 12-months stood at 0.7052.
Flora Growth Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $77.04 million
- Total Liabilities
- $15.50 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $102000
- Dividend Payout Ratio
- 0%
Flora Growth Corp ended 2025 with $77.04 million in total assets and $0 in total liabilities. Its intangible assets were valued at $77.04 million while shareholder equity stood at $54.05 million.
Flora Growth Corp ended 2025 with $0 in deferred long-term liabilities, $15.50 million in other current liabilities, in common stock, $-93976000.00 in retained earnings and $23.37 million in goodwill. Its cash balance stood at $5.26 million and cash and short-term investments were $5.26 million. The company’s total short-term debt was $2,327,000 while long-term debt stood at $0.
Flora Growth Corp’s total current assets stands at $27.88 million while long-term investments were $730000.00 and short-term investments were $0. Its net receivables were $10.43 million compared to accounts payable of $6.32 million and inventory worth $10.31 million.
In 2025, Flora Growth Corp's operating cash flow was $0 while its capital expenditure stood at $102000.
Comparatively, Flora Growth Corp paid $0 in dividends in 2025.
Other key metrics
- Current Trading Price
- $3.4
- 52-Week High
- $1.27
- 52-Week Low
- $0.172
- Analyst Target Price
- $1
Flora Growth Corp stock is currently trading at $3.4 per share. It touched a 52-week high of $1.27 and a 52-week low of $1.27. Analysts tracking the stock have a 12-month average target price of $1.
Its 50-day moving average was $2.51 and 200-day moving average was $4.82 The short ratio stood at 0.26 indicating a short percent outstanding of 0%.
Around 1515.6% of the company’s stock are held by insiders while 1298.6% are held by institutions.
Frequently Asked Questions About Flora Growth Corp
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers fruit juices and canned goods in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it provides beverage products; cannabis formulations to treat ailments, such as anxiety, insomnia, and pain. The company sells its products under the JustCBD, Vessel, and Mambe, as well as Stardog Loungewear, No Cap Hemp Co, Original Hemp, Kalaya, and Mind Naturals brands. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.